Deal-to-Dollar Attribution Capital Allocation NPV Analysis DCF Valuation Committed Capital

Novo Nordisk Akero Therapeutics Embark Biotech Catalent

Novo Nordisk: what will come out from the shopping bag of 100 year old Insulin Maker?

Novo Nordisk deployed billions in obesity and diabetes bets since 2023. Did they allocate capital to the right stage and modality? Read the analysis deal by deal to reveal the truth.